Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Leica Biosystems — FDA PMA Approvals: 0 in FY2025, down 100.0% from a year earlier. That is the lowest of the 10 years on record here.
Latest, FY2025
0
Period ended Dec 31, 2025
Change on a year earlier
-100.0%
1 in FY2024
History
10 years
Since FY2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)
Where the FY2025 figure comes from
Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Reported in U.S. FDA openFDA Device PMA API.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Leica Biosystems — FDA PMA Approvals | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | -100.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2024 | Dec 31, 2024 | 1 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2023 | Dec 31, 2023 | 0 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2022 | Dec 31, 2022 | 0 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2021 | Dec 31, 2021 | 0 | -100.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2020 | Dec 31, 2020 | 3 | -25.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2019 | Dec 31, 2019 | 4 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2018 | Dec 31, 2018 | 0 | -100.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2017 | Dec 31, 2017 | 2 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2015 | Dec 31, 2015 | 2 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
Cite this data
StockData. (2026). Danaher Leica Biosystems — FDA PMA Approvals, annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-pma-leica-biosystems
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.